Announcements Trials
Browse Landscape

Status

Completed 5Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Fatigue 5Breast Neoplasms 5Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Depression 2Congenital Abnormalities 2Carcinoma, Ovarian Epithelial 2Vomiting 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Sexuality 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Nausea 1Myeloproliferative Disorders 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Dexamethasone 14Rituximab 6Cytarabine 5venetoclax 4Lenalidomide 4Bortezomib 4Bendamustine Hydrochloride 4selinexor 3pomalidomide 3pembrolizumab 3ibrutinib 3fludarabine 3carfilzomib 3Paclitaxel 3Gemcitabine 3Drug Therapy 3Cyclophosphamide 3Calcium Dobesilate 3ixazomib 2gilteritinib 2fludarabine phosphate 2elotuzumab 2daratumumab 2belinostat 2Tablets 2Surveys and Questionnaires 2Panobinostat 2Oxaliplatin 2Granulocyte Colony-Stimulating Factor 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Recurrence × Therapeutics × Clear all
NCT00402935 2012-03-20

Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

Case Comprehensive Cancer Center

Withdrawn
LymphoidOtherOther hematologic neoplasm

Congenital Abnormalities, Hodgkin Disease, Infertility, Leukemia, Lymphoma, Recurrence, Sexual Dysfunction, Physiological, Leukemia, Myeloid, Acute, Sexuality, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡